Abstract
Despite improvements in contraceptive technology and a growing market of effective and safe contraceptive options, unintended pregnancy continues to be a significant public health issue in the United States. The more than 2.5 million unintended pregnancies in the United States each year make up nearly half (49%) of all pregnancies. During their reproductive years, 48% of women will have an unintended pregnancy. Adolescents and women in poverty are at highest risk of having an unplanned birth (1), an event that may further challenge their ability to obtain an education, appropriate job training, and a meaningful job.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Henshaw SK. (1998) Unintended pregnancy in the United States. Fam Plan Persp 30:24–29, 46.
Mosher WD, Martinez GM, Chandra A, Abma JC, Wilson SJ. (2004) Use of contraception and use of family planning services in the United States: 1998-2002. Adv Data Stat 350: Dec. 10.
Vessey, Lawless M, Yeates D. (1982) Efficacy of different contraceptive methods. Lancet 1:841–842.
Sivin I, Schmidt F. (1987) Effectiveness of IUDs: a review. Contraception 36:55–84.
Trussell J, Leveque JA, Koenig JD, et al. (1995) The economic value of contraception: a comparison of 15 methods. Am J Public Health 954:494–503.
Alan Guttmacher Institute, and Fu H, Darroch JE, Haas T, et al. (1999) Contraceptive failure rates: new estimates from the 1995 National Survey of Family Growth. Fam Plann Perspect 31:2.
Trussell J. (1998) Contraceptive efficacy. In:Hatcher RA, Trussell J, Stewart F, et al., eds. Contraceptive Technology, 17th edition. New York: Ardent, pp. 779–844.
Trussell J. (2004) The essentials of contraception: efficacy, safety, and personal considerations. In: Hatcher RA, Trussell J, Stewart F, et al., eds. Contraceptive Technology, 18th edition. New York: Ardent, pp. 211–248.
Schwallie PC, Assenzo JR. (1973) Contraceptive use — efficacy study utilizing medroxyprogesterone acetate administered as an intramuscular injection once every 90 days. Fert Steril 24:331–339.
McCann MF, Potter LS.(1994) Progestin-only oral contraception: a comprehensive review. Contraception 50(Suppl):S1–S195.
Wilcox AJ, Dunson D, Baird DD. (2000) The timing of the “fertile window” in the menstrual cycle: day-specific estimates from a perspective study. BMJ 321:1259–1262.
Areevalo M, Jennings V, Sinai I. (2002) Efficacy of a new method of family planning: the standard days method. Contraception 65:333–338.
Klaus H.(1995) Natural Family Planning: A Review, 2nd edition. Bethesda, MD: Natural Family Planning Center of Washington, DC.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Shoupe, D. (2006). Contraceptive Overview. In: Shoupe, D., Kjos, S.L. (eds) The Handbook of Contraception. Current Clinical Practice. Humana Press. https://doi.org/10.1007/978-1-59745-150-5_1
Download citation
DOI: https://doi.org/10.1007/978-1-59745-150-5_1
Publisher Name: Humana Press
Print ISBN: 978-1-58829-599-6
Online ISBN: 978-1-59745-150-5
eBook Packages: MedicineMedicine (R0)